Charco Neurotech

Charco Neurotech is a medical device company that develops non-invasive wearable technology for people with Parkinson disease. The company has developed a wearable device that uses targeted vibration therapy to reduce the motor symptoms of Parkinson disease, including tremors, rigidity, and bradykinesia. The device is designed to be worn discreetly and provides continuous symptom management without medication, offering an adjunct therapy option for Parkinson patients. Charco Neurotech technology is based on research into the effects of focused mechanical stimulation on neural circuits affected by Parkinson disease, providing a drug-free approach to symptom relief that can improve quality of life for patients. Founded in 2019 and headquartered in Cambridge, United Kingdom, the company has raised approximately $17.7 million in seed funding from investors including Amadeus Capital, Parkwalk, UTEC, and RCA.